The neuro-modulatory actions at CB1 receptors by endocannabinoids, of which anandamide and 2-arachidonoylglycerol are the two most studied representatives, allows them to counteract the neuro-chemical imbalances arising during Alzheimer’s disease, multiple sclerosis, amyotropic lateral sclerosis, Parkinson’s disease, and Huntington’s chorea.
Link: Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
Year: 2010
DOI: 10.2174/187152710793361568
Likely probability of the efficacy of cannabis for treatment of Huntington's Disease according to the results found in this study.
Likely probability of the efficacy of cannabis for treatment of Alzheimer's Disease according to the results found in this study.
Likely probability of the efficacy of cannabis for treatment of Parkinson's Disease according to the results found in this study.
Likely probability of the efficacy of cannabis for treatment of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) according to the results found in this study.
Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.
Cannabinoids
Endocannabinoids